Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parkinson's Disease

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    September 2022
  1. FUNG WK, Cohn M, Lang AE, Fasano A, et al
    Precision vs. Personalized DBS for GBA-related Parkinson disease.
    Ann Neurol. 2022 Sep 2. doi: 10.1002/ana.26499.
    PubMed    


    August 2022
  2. AL-MUBARAK B, Ahmed Nour M, Schumacher-Schuh A, Bandres-Ciga S, et al
    Globalizing research towards diverse representation in Alzheimer's and Parkinson's disease.
    Ann Neurol. 2022 Aug 24. doi: 10.1002/ana.26483.
    PubMed    


  3. MARIN-LAHOZ J, Martinez-Horta S, Pagonabarraga J, Horta-Barba A, et al
    Predicting Impulse Control Disorders in Parkinson's disease through incentive biomarkers.
    Ann Neurol. 2022 Aug 19. doi: 10.1002/ana.26486.
    PubMed     Abstract available


  4. PERINAN MT, Brolin K, Bandres-Ciga S, Blauwendraat C, et al
    Effect modification between genes and environment, and Parkinson's disease risk.
    Ann Neurol. 2022 Aug 1. doi: 10.1002/ana.26467.
    PubMed     Abstract available


    July 2022
  5. KENT DM, Leung LY, Puttock EJ, Wang AY, et al
    Development of Parkinson's disease and its relationship with incidentally-discovered white matter disease and covert brain infarction in a real-world cohort.
    Ann Neurol. 2022 Jul 22. doi: 10.1002/ana.26458.
    PubMed     Abstract available


  6. BOLLIRI C, Fontana A, Cereda E, Barichella M, et al
    Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease.
    Ann Neurol. 2022 Jul 19. doi: 10.1002/ana.26454.
    PubMed     Abstract available


    June 2022
  7. PRANGE S, Lin Z, Nourredine M, Danaila T, et al
    Limbic stimulation drives mania in STN-DBS in Parkinson disease: a prospective study.
    Ann Neurol. 2022 Jun 15. doi: 10.1002/ana.26434.
    PubMed     Abstract available


  8. PAL G, Mangone G, Ouyang B, Ehrlich D, et al
    Reply to: Cognitive effects of deep brain stimulation in GBA-related Parkinson's disease.
    Ann Neurol. 2022 Jun 10. doi: 10.1002/ana.26433.
    PubMed    


  9. WEILL C, Gallant A, Lintsky E, Dienstag A, et al
    Cognitive effects of deep brain stimulation in GBA-related Parkinson's disease.
    Ann Neurol. 2022 Jun 10. doi: 10.1002/ana.26432.
    PubMed    


    May 2022
  10. LIU H, Dehestani M, Blauwendraat C, Makarious MB, et al
    Polygenic resilience modulates the penetrance of Parkinson's disease genetic risk factors.
    Ann Neurol. 2022 May 22. doi: 10.1002/ana.26416.
    PubMed     Abstract available


  11. HUANG Y, Liu Z, Li N, Tian C, et al
    Parkinson's disease derived exosomes aggravate neuropathology in SNCA*A53T mice.
    Ann Neurol. 2022 May 21. doi: 10.1002/ana.26421.
    PubMed     Abstract available


  12. SHEN J, Amari N, Zack R, Skrinak RT, et al
    Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson's Disease.
    Ann Neurol. 2022 May 20. doi: 10.1002/ana.26410.
    PubMed     Abstract available


    April 2022
  13. CRAMER SW, Do TH, Palzer EF, Naik A, et al
    Persistent racial disparities in deep brain stimulation for Parkinson's disease.
    Ann Neurol. 2022 Apr 19. doi: 10.1002/ana.26378.
    PubMed     Abstract available


  14. FURUKAWA K, Shima A, Kambe D, Nishida A, et al
    Motor progression and nigrostriatal neurodegeneration in Parkinson's disease.
    Ann Neurol. 2022 Apr 15. doi: 10.1002/ana.26373.
    PubMed     Abstract available


    February 2022
  15. MONTENEGRO P, Pueyo M, Lorenzo JN, Villar MD, et al
    A secretory vesicle failure in Parkinson's disease occurs in human platelets.
    Ann Neurol. 2022 Feb 28. doi: 10.1002/ana.26335.
    PubMed     Abstract available


    January 2022
  16. TOSSERAMS A, Weerdesteyn V, Bal T, Bloem BR, et al
    Cortical correlates of gait compensation strategies in Parkinson's disease.
    Ann Neurol. 2022 Jan 24. doi: 10.1002/ana.26306.
    PubMed     Abstract available


  17. PAL G, Mangone G, Hill EJ, Ouyang B, et al
    Parkinson disease and STN-DBS: cognitive effects in GBA mutation carriers.
    Ann Neurol. 2022 Jan 4. doi: 10.1002/ana.26302.
    PubMed     Abstract available


    December 2021
  18. JOHANSSON ME, Cameron IGM, van der Kolk NM, De Vries NM, et al
    Aerobic exercise alters brain function and structure in Parkinson's disease a randomized controlled trial.
    Ann Neurol. 2021 Dec 24. doi: 10.1002/ana.26291.
    PubMed     Abstract available


    November 2021
  19. VILLANUEVA EB, Tresse E, Liu Y, Duarte JN, et al
    Neuronal TNFalpha, Not alpha-Syn, Underlies PDD-Like Disease Progression in IFNbeta-KO Mice.
    Ann Neurol. 2021;90:789-807.
    PubMed     Abstract available


    August 2021
  20. ZHANG C, Lai Y, Li J, He N, et al
    Subthalamic and pallidal stimulations in patients with Parkinson's disease: common and dissociable connections.
    Ann Neurol. 2021 Aug 14. doi: 10.1002/ana.26199.
    PubMed     Abstract available


  21. VERGER A, Grimaldi S, Ribeiro MJ, Frismand S, et al
    SPECT/PET molecular imaging for parkinsonism: a fast-developing field.
    Ann Neurol. 2021 Aug 2. doi: 10.1002/ana.26187.
    PubMed     Abstract available


    July 2021
  22. TAN EK
    Genetic studies of Parkinson's & Alzheimer's disease in Latinos/Hispanics: New Insights & Challenges.
    Ann Neurol. 2021 Jul 26. doi: 10.1002/ana.26179.
    PubMed    


  23. WEISS D, Volkmann J, Fasano A, Kuhn A, et al
    Neurology Grand Rounds: Changing gears - DBS for dopaminergic desensitization in Parkinson's disease?
    Ann Neurol. 2021 Jul 7. doi: 10.1002/ana.26164.
    PubMed     Abstract available


  24. LOESCH DP, Horimoto ARVR, Heilbron K, Sarihan EI, et al
    Characterizing the Genetic Architecture of Parkinson's Disease in Latinos.
    Ann Neurol. 2021 Jul 6. doi: 10.1002/ana.26153.
    PubMed     Abstract available


    June 2021
  25. DARVISH H, Azcona LJ, Taghavi S, Firouzabadi SG, et al
    ANXA1 with anti-inflammatory properties might contribute to parkinsonism.
    Ann Neurol. 2021 Jun 28. doi: 10.1002/ana.26148.
    PubMed     Abstract available


  26. SINGER W, Schmeichel AM, Shahnawaz M, Schmelzer JD, et al
    Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure.
    Ann Neurol. 2021;89:1212-1220.
    PubMed     Abstract available


    May 2021
  27. HEINZEL S, Aho VTE, Suenkel U, von Thaler AK, et al
    Gut microbiome signatures of risk and prodromal markers of Parkinson's disease.
    Ann Neurol. 2021 May 22. doi: 10.1002/ana.26128.
    PubMed     Abstract available


  28. ALBIN RL, Muller MLTM, Bohnen NI, Spino C, et al
    alpha4beta2(*) Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders.
    Ann Neurol. 2021 May 11. doi: 10.1002/ana.26102.
    PubMed     Abstract available


  29. LAI D, Alipanahi B, Fontanillas P, Schwantes-An TH, et al
    Genome-wide association studies of LRRK2 modifiers of Parkinson's disease.
    Ann Neurol. 2021 May 2. doi: 10.1002/ana.26094.
    PubMed     Abstract available


  30. KLEIN C, Konig IR
    Exploring uncharted territory: genetically determined sex differences in Parkinson's disease.
    Ann Neurol. 2021 May 2. doi: 10.1002/ana.26091.
    PubMed    


    April 2021
  31. BLAUWENDRAAT C, Iwaki H, Makarious MB, Bandres-Ciga S, et al
    Investigation of Autosomal Genetic Sex Differences in Parkinson's disease.
    Ann Neurol. 2021 Apr 26. doi: 10.1002/ana.26090.
    PubMed     Abstract available


  32. RUSZ J, Hlavnicka J, Novotny M, Tykalova T, et al
    Speech biomarkers in rapid eye movement sleep behaviour disorder and Parkinson's disease.
    Ann Neurol. 2021 Apr 15. doi: 10.1002/ana.26085.
    PubMed     Abstract available


    March 2021
  33. ROSEBRAUGH M, Voight EA, Moussa EM, Jameel F, et al
    Foslevodopa/foscarbidopa: a new subcutaneous treatment for Parkinson's disease.
    Ann Neurol. 2021 Mar 26. doi: 10.1002/ana.26073.
    PubMed     Abstract available


  34. ELIAS GJB, Boutet A, Joel SE, Germann J, et al
    Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy.
    Ann Neurol. 2021;89:426-443.
    PubMed     Abstract available


    February 2021
  35. LE GUEN Y, Napolioni V, Belloy ME, Yu E, et al
    Common X-chromosome variants are associated with Parkinson's disease risk.
    Ann Neurol. 2021 Feb 14. doi: 10.1002/ana.26051.
    PubMed     Abstract available


  36. JENSEN MP, Jacobs BM, Dobson R, Bandres-Ciga S, et al
    Lower lymphocyte count is associated with increased risk of Parkinson's disease.
    Ann Neurol. 2021 Feb 2. doi: 10.1002/ana.26034.
    PubMed     Abstract available


  37. RAHAYEL S, Postuma RB, Montplaisir J, Misic B, et al
    A Prodromal Brain-Clinical Pattern of Cognition in Synucleinopathies.
    Ann Neurol. 2021;89:341-357.
    PubMed     Abstract available


  38. STANG CD, Mullan AF, Hajeb M, Camerucci E, et al
    Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha-Synucleinopathies.
    Ann Neurol. 2021;89:293-303.
    PubMed     Abstract available


    January 2021
  39. ANDERSEN MS, Bandres-Ciga S, Reynolds RH, Hardy J, et al
    Heritability enrichment implicates microglia in Parkinson's disease pathogenesis.
    Ann Neurol. 2021 Jan 27. doi: 10.1002/ana.26032.
    PubMed     Abstract available


    December 2020
  40. YAU WY, Sullivan R, Rocca C, Cali E, et al
    NOTCH2NLC Intermediate-length Repeat Expansion and Parkinson's Disease in Patients of European Descent.
    Ann Neurol. 2020 Dec 30. doi: 10.1002/ana.26003.
    PubMed    


  41. SHI CH, Fan Y, Xu YM
    Reply to "NOTCH2NLC Intermediate-length Repeat Expansion and Parkinson's Disease".
    Ann Neurol. 2020 Dec 30. doi: 10.1002/ana.26005.
    PubMed    


  42. CAVALLIERI F, Fraix V, Bove F, Mulas D, et al
    Predictors of long-term outcome of subthalamic stimulation in Parkinson disease.
    Ann Neurol. 2020 Dec 21. doi: 10.1002/ana.25994.
    PubMed     Abstract available


  43. TAN AH, Chong CW, Lim SY, Yap IKS, et al
    Gut microbial ecosystem in Parkinson's disease: New clinico-biological insights from multi-omics.
    Ann Neurol. 2020 Dec 3. doi: 10.1002/ana.25982.
    PubMed     Abstract available


  44. SHEN L, Jiang C, Hubbard CS, Ren J, et al
    Subthalamic Nucleus Deep Brain Stimulation Modulates 2 Distinct Neurocircuits.
    Ann Neurol. 2020;88:1178-1193.
    PubMed     Abstract available


    November 2020
  45. LEE JY, Ahn J, Shin J, Jeon B, et al
    Parafovea change and dopamine loss in the retina with Parkinson's disease.
    Ann Neurol. 2020 Nov 24. doi: 10.1002/ana.25972.
    PubMed    


    October 2020
  46. KIM CY, Wirth T, Hubsch C, Nemeth AH, et al
    Reply to "PPP2R5D genetic mutations and early-onset parkinsonism".
    Ann Neurol. 2020 Oct 24. doi: 10.1002/ana.25945.
    PubMed    


  47. MURUETA-GOYENA A, Del Pino R, Galdos M, Arana B, et al
    Retinal thickness predicts the risk of cognitive decline in Parkinson's disease.
    Ann Neurol. 2020 Oct 24. doi: 10.1002/ana.25944.
    PubMed     Abstract available


  48. DULOVIC-MAHLOW M, Konig IR, Trinh J, Diaw SH, et al
    Discordant monozygotic Parkinson disease twins: Role of mitochondrial integrity.
    Ann Neurol. 2020 Oct 23. doi: 10.1002/ana.25942.
    PubMed     Abstract available


  49. WALKER IM, Riboldi GM, Drummond P, Saade-Lemus S, et al
    PPP2R5D genetic mutations and early-onset parkinsonism.
    Ann Neurol. 2020 Oct 23. doi: 10.1002/ana.25943.
    PubMed    


  50. ESPAY AJ, Marsili L, Mahajan A, Sturchio A, et al
    Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.
    Ann Neurol. 2020 Oct 5. doi: 10.1002/ana.25923.
    PubMed     Abstract available


  51. SHI CH, Fan Y, Yang J, Yuan YP, et al
    NOTCH2NLC Intermediate-length Repeat Expansions are Associated with Parkinson's Disease.
    Ann Neurol. 2020 Oct 5. doi: 10.1002/ana.25925.
    PubMed     Abstract available


  52. LESAGE S, Lunati A, Houot M, Romdhan SB, et al
    Characterization of Recessive Parkinson Disease in a Large Multicenter Study.
    Ann Neurol. 2020;88:843-850.
    PubMed     Abstract available


    September 2020
  53. NUBER S, Nam AY, Rajsombath MM, Cirka H, et al
    A stearoyl-CoA desaturase inhibitor prevents multiple Parkinson's disease-phenotypes in alpha-synuclein mice.
    Ann Neurol. 2020 Sep 29. doi: 10.1002/ana.25920.
    PubMed     Abstract available


  54. SINGER W, Schmeichel AM, Shahnawaz M, Schmelzer JD, et al
    Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies.
    Ann Neurol. 2020;88:503-512.
    PubMed     Abstract available


    June 2020
  55. IRMEN F, Horn A, Mosley P, Perry A, et al
    Left Prefrontal Connectivity Links Subthalamic Stimulation with Depressive Symptoms.
    Ann Neurol. 2020;87:962-975.
    PubMed     Abstract available


  56. MONZON-SANDOVAL J, Poggiolini I, Ilmer T, Wade-Martins R, et al
    Human-Specific Transcriptome of Ventral and Dorsal Midbrain Dopamine Neurons.
    Ann Neurol. 2020;87:853-868.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: